PROM1 and atrial fibrillation: Beyond that, it is clear from our flow cytometric analysis and immunohistological studies that Lin-CD34+ and Lin-CD133+ stem cells in blood and CD133+ stem cells in the remnant liver are significantly higher in animals with AF combination therapy.